Zacks Investment Research upgraded shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) from a sell rating to a hold rating in a research report released on Thursday.
According to Zacks, “Reckitt Benckiser Group Plc engages in manufacturing and distributing household, toiletry, pharmaceutical and food products. The company offers antiseptic liquids, depilatory products, medicated sore throat products, condoms, cold/flu products, acne treatment products, analgesics and upper gastro-intestinal products, foot care and comfort footwear products, denture care and dry skin care products, fabric care products, surface care products and polishes/waxes. Reckitt Benckiser Group is based in Slough, the United Kingdom. “
Several other equities research analysts have also commented on RBGLY. BNP Paribas lowered shares of Reckitt Benckiser Group PLC from an outperform rating to a neutral rating in a research report on Wednesday, September 7th. Credit Suisse Group AG reduced their price objective on Reckitt Benckiser Group PLC from $6,500.00 to $6,100.00 and set an outperform rating on the stock in a research note on Thursday, August 25th. Citigroup Inc. began coverage on Reckitt Benckiser Group PLC in a research note on Thursday, September 1st. They set a buy rating on the stock. Finally, JPMorgan Chase & Co. restated a neutral rating on shares of Reckitt Benckiser Group PLC in a research note on Thursday, September 22nd. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has an average rating of Buy and a consensus price target of $3,061.50.
Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) opened at 16.95 on Thursday. The company’s 50-day moving average is $17.92 and its 200-day moving average is $19.32. The stock has a market cap of $59.76 billion, a P/E ratio of 32.07 and a beta of 0.92. Reckitt Benckiser Group PLC has a 12-month low of $16.90 and a 12-month high of $20.70.
Reckitt Benckiser Group PLC Company Profile